Animal model of anxiety: the effect of chronic dihydroergotoxine treatment in the genetically hypertensive rats of Koletsky type and in the rats of Wistar strain
Language English Country Czech Republic Media print
Document type Journal Article
PubMed
2098906
Knihovny.cz E-resources
- MeSH
- Behavior, Animal drug effects MeSH
- Dihydroergotoxine pharmacology therapeutic use MeSH
- Hypertension physiopathology psychology MeSH
- Rats, Inbred Strains MeSH
- Rats MeSH
- Rats, Inbred SHR MeSH
- Anxiety drug therapy MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Dihydroergotoxine MeSH
The observations were carried out in the adult normotensive rats of Wistar strain and in the genetically hypertensive rats developed by Koletsky, i.e., in the strain where is decreased turnover-rate of diencephalo-mesecephalic norepinephrine, increased CNS cholinergic activity accompanied by cholinergic supersensitivity and reduced stress-resistance. The effect of dihydroergotoxine was traced in holeboard and in the elevated plus-maze. Chronic dihydroergotoxine treatment shows "anxiolytic" effect in the elevated plus-maze (i.e., this drug alleviates aversion towards open space and height), increases directed exploration, elevates the rate of habituation of the locomotor-exploratory activity at all, and elevates the rate of habituation of directed exploration especially. The drug in the above mentioned parameters shows very expressive dependent effect, i.e., the effect being more or solely expressed in the genetically hypertensive rats of Koletsky type. The results of our recent series of experiments again suggest that is is well founded to use for the screening of the drugs with potential anxiolytic effect the genetically hypertensive rats of Koletsky type, i.e., the strain which by its CNS neurotransmitter abnormalities resembles deviations observed in the patients suffering from anxio-depressive disorders.